
Ginkgo biloba
Ginkgo biloba is a plant extract rich in flavonoids and terpene lactones (ginkgolides and bilobalide). It is studied mainly for its effects on cerebral perfusion, oxidative stress, and neuroinflammation. Clinical results are heterogeneous: some studies show modest benefits for memory/attention in specific populations, whereas in healthy subjects the effect is often small or inconsistent.
Nootropic phytocompound: microcirculation, neuroprotection, and cognitive function (variable evidence)
Ginkgo biloba is a plant extract rich in flavonoids and terpene lactones (ginkgolides and bilobalide). It is studied mainly for its effects on cerebral perfusion, oxidative stress, and neuroinflammation. Clinical results are heterogeneous: some studies show modest benefits for memory/attention in specific populations, while in healthy subjects the effect is often small or inconsistent.
Mechanism of action
Proposed mechanisms (not all definitively confirmed in humans): (1) antioxidant action and scavenging of reactive oxygen species; (2) modulation of endothelial function and microcirculation (possible improvement in tissue perfusion); (3) anti-inflammatory effects and modulation of neuronal signaling pathways; (4) antagonism of PAF (platelet-activating factor) attributed to ginkgolides, with potential impact on platelet aggregation and vascular tone; (5) effects on neurotransmission (cholinergic, monoaminergic) and synaptic plasticity reported in preclinical models. Clinical relevance varies and may be influenced by dose, standardization, and the subject’s baseline status.
Supported benefits
- Modest improvement in some cognitive domains (memory/attention) in older adults and/or in the presence of mild cognitive decline or dementia, especially with standardized extracts and treatments lasting weeks to months (moderate)
- Reduction of symptoms associated with cerebrovascular insufficiency/vertigo and some subjective disorders (variable outcomes across studies) (limited)
- Support for mild anxiety symptoms (some RCTs show reductions, but heterogeneity and risk of bias remain) (limited)
- Prevention of cognitive decline or dementia in the general population (prevention studies with often null or inconclusive results) (limited)
- Improvement in cognitive performance in young/healthy subjects (small and inconsistent effects) (emerging)
Safety & side effects
- Gastrointestinal disturbances (nausea, dyspepsia, diarrhea)
- Headache, dizziness
- Insomnia or restlessness in some subjects
- Skin/allergic reactions (more likely with low-quality products or contaminants)
- Abnormal bleeding: a rare but clinically relevant event, especially in the presence of risk factors or concomitant medications
FAQ
Does Ginkgo biloba improve memory in healthy subjects?
Evidence in young/healthy subjects is inconsistent: some studies report small improvements in specific tests, while others show no differences. When present, the effects tend to be modest and depend on dose, duration, and extract standardization.
How important is extract standardization?
Very important. The most cited clinical studies use standardized extracts with a defined profile of flavonoids and terpene lactones and low ginkgolic acids. Non-standardized products may have unpredictable efficacy and a worse safety profile.
Is it true that it increases the risk of bleeding?
There is biological plausibility (PAF antagonism) and clinical reports, especially in combination with drugs that affect coagulation/platelet aggregation. The absolute risk is generally low, but it can become relevant in predisposed subjects or with concomitant therapy.
How long does it take to notice any effects?
In studies on cognition/decline, when benefits are observed, they often emerge after several weeks of continuous use. Acute effects on focus are less predictable.
Is Ginkgo useful for tinnitus or vertigo?
Overall results are inconclusive and depend on the cause of the symptom and the protocol. In some vestibular conditions, improvements have been reported, but this is not a consistent outcome across studies.
The information provided is for informational and educational purposes only. It does not constitute medical advice. Use should be evaluated and authorized by a qualified healthcare professional.
Mechanism of action
Proposed mechanisms (not all definitively confirmed in humans): (1) antioxidant action and scavenging of reactive oxygen species; (2) modulation of endothelial function and microcirculation (possible improvement in tissue perfusion); (3) anti-inflammatory effects and modulation of neuronal signaling pathways; (4) antagonism of PAF (platelet-activating factor) attributed to ginkgolides, with potential impact on platelet aggregation and vascular tone; (5) effects on neurotransmission (cholinergic, monoaminergic) and synaptic plasticity reported in preclinical models. Clinical relevance varies and may be influenced by dose, standardization, and the subject’s baseline status.
Scientific benefits
Contraindications
- Coagulation disorders or history of significant bleeding (clinical evaluation required)
- Perioperative use: preventive discontinuation is often recommended in clinical settings due to the possible increased risk of bleeding (timing to be defined with a healthcare professional)
- Pregnancy and breastfeeding: insufficient safety data; avoid unless otherwise directed by a physician
- Epilepsy or predisposition to seizures: caution due to rare reports and potentially pro-convulsant mechanisms under specific conditions
- Known allergy to Ginkgo or components of the extract
Side effects
- Gastrointestinal disorders (nausea, dyspepsia, diarrhea)
- Headache, dizziness
- Insomnia or restlessness in some individuals
- Skin/allergic reactions (more likely with low-quality products or contaminants)
- Abnormal bleeding: a rare but clinically relevant event, especially in the presence of risk factors or concomitant medications
Interactions
- Anticoagulants (e.g. warfarin) and antiplatelet agents (e.g. aspirin, clopidogrel): possible increased risk of bleeding
- NSAIDs (e.g. ibuprofen, naproxen): potential increase in gastrointestinal bleeding risk in predisposed individuals
- SSRIs/SNRIs and other drugs that may affect hemostasis: possible increased risk of bleeding (variable evidence)
- Antiepileptic drugs: caution due to possible interactions and rare reports of seizures
- Drugs metabolized by CYP: interactions are possible but not consistent; they depend on the extract and dose (case-by-case evaluation)
Regulatory status
In many countries it is marketed as a dietary supplement; in some contexts there are also registered herbal medicinal products with standardized extracts. Regulation varies by country (permitted claims, quality standards, limits on ginkgolic acids).
Supplements and peptides
Focus & NootropicsAgmatine sulfate
Agmatine is an endogenous metabolite produced by decarboxylation of L-arginine. In supplementation contexts it is…
Focus & NootropicsAlpha-gpc
Alpha-GPC is a choline-containing compound (a precursor of acetylcholine) and an intermediate in phospholipid…
Focus & NootropicsAnhydrous caffeine
Anhydrous caffeine is the dehydrated form of caffeine, used in supplements for its high concentration and dosing…